Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Related Articles by Review for PubMed (Select 21633037)

1.

Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques.

Osorio JE, Brewoo JN, Silengo SJ, Arguello J, Moldovan IR, Tary-Lehmann M, Powell TD, Livengood JA, Kinney RM, Huang CY, Stinchcomb DT.

Am J Trop Med Hyg. 2011 Jun;84(6):978-87. doi: 10.4269/ajtmh.2011.10-0592.

2.

Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.

Osorio JE, Huang CY, Kinney RM, Stinchcomb DT.

Vaccine. 2011 Sep 23;29(42):7251-60. doi: 10.1016/j.vaccine.2011.07.020. Epub 2011 Jul 21. Review.

PMID:
21777638
3.

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.

Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J.

Vaccine. 2011 Sep 23;29(42):7229-41. doi: 10.1016/j.vaccine.2011.06.094. Epub 2011 Jul 13. Review.

PMID:
21745521
4.

Dengue vaccine candidates in development.

Durbin AP, Whitehead SS.

Curr Top Microbiol Immunol. 2010;338:129-43. doi: 10.1007/978-3-642-02215-9_10. Review.

PMID:
19802583
5.

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.

Coller BA, Clements DE, Bett AJ, Sagar SL, Ter Meulen JH.

Vaccine. 2011 Sep 23;29(42):7267-75. doi: 10.1016/j.vaccine.2011.07.021. Epub 2011 Jul 21. Review.

6.

Immune response to dengue virus and prospects for a vaccine.

Murphy BR, Whitehead SS.

Annu Rev Immunol. 2011;29:587-619. doi: 10.1146/annurev-immunol-031210-101315. Review.

PMID:
21219187
7.

Current progress in dengue vaccines.

Wan SW, Lin CF, Wang S, Chen YH, Yeh TM, Liu HS, Anderson R, Lin YS.

J Biomed Sci. 2013 Jun 13;20:37. doi: 10.1186/1423-0127-20-37. Review.

8.

Identifying protective dengue vaccines: guide to mastering an empirical process.

Halstead SB.

Vaccine. 2013 Sep 23;31(41):4501-7. doi: 10.1016/j.vaccine.2013.06.079. Epub 2013 Jul 26. Review.

9.

Prospects for a dengue virus vaccine.

Whitehead SS, Blaney JE, Durbin AP, Murphy BR.

Nat Rev Microbiol. 2007 Jul;5(7):518-28. Review.

PMID:
17558424
10.

Current issues in dengue vaccination.

Thomas SJ, Endy TP.

Curr Opin Infect Dis. 2013 Oct;26(5):429-34. doi: 10.1097/01.qco.0000433310.28771.cc. Review.

PMID:
23963259
11.

Dengue virus vaccine development.

Yauch LE, Shresta S.

Adv Virus Res. 2014;88:315-72. doi: 10.1016/B978-0-12-800098-4.00007-6. Review.

PMID:
24373316
12.

Challenges for the formulation of a universal vaccine against dengue.

Chokephaibulkit K, Perng GC.

Exp Biol Med (Maywood). 2013 May;238(5):566-78. doi: 10.1177/1535370212473703. Review.

PMID:
23856907
13.

Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis.

Rainwater-Lovett K, Rodriguez-Barraquer I, Cummings DA, Lessler J.

BMC Infect Dis. 2012 Sep 28;12:233. doi: 10.1186/1471-2334-12-233. Review.

14.

Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: a meta-analysis of randomized trials.

da Costa VG, Marques-Silva AC, Floriano VG, Moreli ML.

Vaccine. 2014 Sep 3;32(39):4885-92. doi: 10.1016/j.vaccine.2014.07.008. Epub 2014 Jul 19. Review.

PMID:
25045816
15.

Targeted mutagenesis as a rational approach to dengue virus vaccine development.

Blaney JE Jr, Durbin AP, Murphy BR, Whitehead SS.

Curr Top Microbiol Immunol. 2010;338:145-58. doi: 10.1007/978-3-642-02215-9_11. Review.

16.
17.

Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine.

Durbin AP, Kirkpatrick BD, Pierce KK, Schmidt AC, Whitehead SS.

Vaccine. 2011 Sep 23;29(42):7242-50. doi: 10.1016/j.vaccine.2011.07.023. Epub 2011 Jul 21. Review.

18.

Dengue vaccines: recent developments, ongoing challenges and current candidates.

McArthur MA, Sztein MB, Edelman R.

Expert Rev Vaccines. 2013 Aug;12(8):933-53. doi: 10.1586/14760584.2013.815412. Review.

19.

Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Mathew A, Townsley E, Ennis FA.

Future Microbiol. 2014;9(3):411-25. doi: 10.2217/fmb.13.171. Review.

20.

Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis.

Althouse BM, Durbin AP, Hanley KA, Halstead SB, Weaver SC, Cummings DA.

Virology. 2014 Mar;452-453:237-46. doi: 10.1016/j.virol.2014.01.015. Epub 2014 Feb 14. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk